<ghs_data xmlns:ghs="http://amrl.engr.ucdavis.edu/ghs_japan" xmlns:py="http://codespeak.net/lxml/objectify/pytype">
  <cas_no>6055-19-2</cas_no>
  <descriptive_name>Cyclophosphamide monohydrate</descriptive_name>
  <date_classified>FY2009</date_classified>
  <ID>6055-19-2</ID>
  <date_imported>Wed Jun 10 13:26:33 2015</date_imported>
  <country>Japan</country>
  <explosives hazard_type="physical">
    <hazard_name>Explosives</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>There are no chemical groups associated with explosive properties present in the molecules.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </explosives>
  <flammable_gases hazard_type="physical">
    <hazard_name>Flammable gases &#65288;including chemically unstable gases&#65289;</hazard_name>
    <hazard_id>2.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </flammable_gases>
  <flammable_aerosols hazard_type="physical">
    <hazard_name>Aerosols</hazard_name>
    <hazard_id>3.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Not aerosol products.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </flammable_aerosols>
  <oxidizing_gases hazard_type="physical">
    <hazard_name>Oxidizing gases</hazard_name>
    <hazard_id>4.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </oxidizing_gases>
  <gases_under_pressure hazard_type="physical">
    <hazard_name>Gases under pressure</hazard_name>
    <hazard_id>5.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </gases_under_pressure>
  <flammable_liquids hazard_type="physical">
    <hazard_name>Flammable liquids</hazard_name>
    <hazard_id>6.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </flammable_liquids>
  <flammable_solids hazard_type="physical">
    <hazard_name>Flammable solids</hazard_name>
    <hazard_id>7.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </flammable_solids>
  <self_reactive_substances hazard_type="physical">
    <hazard_name>Self-reactive substances and mixtures</hazard_name>
    <hazard_id>8.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>There are no chemical groups present in the molecule associated with explosive or self-reactive properties.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </self_reactive_substances>
  <pyrophoric_liquids hazard_type="physical">
    <hazard_name>Pyrophoric liquids</hazard_name>
    <hazard_id>9.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </pyrophoric_liquids>
  <pyrophoric_solids hazard_type="physical">
    <hazard_name>Pyrophoric solids</hazard_name>
    <hazard_id>10.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </pyrophoric_solids>
  <self_heating_substances hazard_type="physical">
    <hazard_name>Self-heating substances and mixtures</hazard_name>
    <hazard_id>11.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Test methods applicable to solid (melting point &lt;= 140 degC) substances are not available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </self_heating_substances>
  <substances_mixtures_emit_flammable_gas_in_contact_with_water hazard_type="physical">
    <hazard_name>Substances and mixtures which, in contact with water, emit flammable gases</hazard_name>
    <hazard_id>12.0</hazard_id>
    <classification>Not classified</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>The substance is considered to be stable against water since data are available that water solubility is 40 g/L (Merck (14th, 2006) though it contains phosphorus.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </substances_mixtures_emit_flammable_gas_in_contact_with_water>
  <oxidizing_liquids hazard_type="physical">
    <hazard_name>Oxidizing liquids</hazard_name>
    <hazard_id>13.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </oxidizing_liquids>
  <oxidizing_solids hazard_type="physical">
    <hazard_name>Oxidizing solids</hazard_name>
    <hazard_id>14.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Classification is not possible since no data are available though the substance is an organic compound containing oxygen which is chemically bonded to phosphorus.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </oxidizing_solids>
  <organic_peroxides hazard_type="physical">
    <hazard_name>Organic peroxides</hazard_name>
    <hazard_id>15.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Organic compounds containing no bivalent -O-O- structure</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </organic_peroxides>
  <corrosive_to_metals hazard_type="physical">
    <hazard_name>Corrosive to metals</hazard_name>
    <hazard_id>16.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Classification is not possible since no data are available though the substance is solid (melting point &lt;= 55 degC).</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </corrosive_to_metals>
  <acute_toxicity_oral hazard_type="health">
    <hazard_name>Acute toxicity &#65288;Oral&#65289;</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Category 3</classification>
    <hazard_statement>Toxic if swallowed</hazard_statement>
    <rationale>Based on a LD50 value of 192.4 mg/kg for rats (IARC vol. 26 (1981)), the substance was classified into Category 3.</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Skull and crossbones</symbol>
  </acute_toxicity_oral>
  <acute_toxicity_dermal hazard_type="health">
    <hazard_name>Acute toxicity &#65288;Dermal&#65289;</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </acute_toxicity_dermal>
  <acute_toxicity_inhalation_gas hazard_type="health">
    <hazard_name>Acute toxicity &#65288;Inhalation: Gases&#65289;</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Not applicable</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>Solid (GHS definition)</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </acute_toxicity_inhalation_gas>
  <acute_toxicity_inhalation_vapor hazard_type="health">
    <hazard_name>Acute toxicity &#65288;Inhalation: Vapours&#65289;</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </acute_toxicity_inhalation_vapor>
  <acute_toxicity_inhalation_dust hazard_type="health">
    <hazard_name>Acute toxicity &#65288;Inhalation: Dusts and mists&#65289;</hazard_name>
    <hazard_id>1.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </acute_toxicity_inhalation_dust>
  <skin_corrosion_irritation hazard_type="health">
    <hazard_name>Skin corrosion/irritation</hazard_name>
    <hazard_id>2.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </skin_corrosion_irritation>
  <serious_eye_damage_irritation hazard_type="health">
    <hazard_name>Serious eye damage/eye irritation</hazard_name>
    <hazard_id>3.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </serious_eye_damage_irritation>
  <respiratory_skin_sensitizer hazard_type="health">
    <hazard_name>Respiratory sensitization</hazard_name>
    <hazard_id>4.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </respiratory_skin_sensitizer>
  <germ_cell_mutagenicity hazard_type="health">
    <hazard_name>Skin sensitization</hazard_name>
    <hazard_id>4.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </germ_cell_mutagenicity>
  <carcinogenicity hazard_type="health">
    <hazard_name>Germ cell mutagenicity</hazard_name>
    <hazard_id>5.0</hazard_id>
    <classification>Category 1B</classification>
    <hazard_statement>May cause genetic defects</hazard_statement>
    <rationale>Based on positive results in rat and mouse dominant lethal tests (in vivo heritable germ cell mutagenicity test) (IARC vol. 26 (1981)), the substance was classified into Category 1B. As relevant information, there are reports of positive chromosomal aberration tests using Chinese hamster and mouse spermatogonial (in vivo mutagenicity tests in germ cell) (IARC vol. 26 (1981)) and positive mouse and rat micronucleus tests using bone marrow and peripheral blood (in vivo somatic cell mutagenicity tests) (NTP DB (access on Oct. 2009)). For humans, it has been reported that there was an increase in the number of chromosomal aberrations in the peripheral blood lymphocytes of children treated with cyclophosphamide for nonmalignant conditions. A similar effect in the peripheral blood lymphocytes was found in patients with rheumatoid arthritis following cyclophosphamide treatment. At 3 or 24-hour after an i.v. administration of cyclophosphamide, patients with recurrent ovarian or uteral carcinoma exhibited similar lymphocytes effects. Changes in bone marrow and lymph-node cells of patients with lymphogranulomatosis were observed at 24 - 72-hour after a single dose of cyclophosphamide (IARC 26 (1981)).</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Health Hazard</symbol>
  </carcinogenicity>
  <toxic_to_reproduction hazard_type="health">
    <hazard_name>Carcinogenicity</hazard_name>
    <hazard_id>6.0</hazard_id>
    <classification>Category 1A</classification>
    <hazard_statement>May cause cancer</hazard_statement>
    <rationale>Based on the classification of "Group 1" in IARC (IARC 100A (2008)), the substance was classified into Category 1A. There were at least 30 case reports of malignancy (nonlymphocytic leukaemias, bladder cancers) in patients treated with the substance, and additionally 83 cases of second malignancy (nonlymphocytic leukaemias, bladder cancers) were reported (IARC 26 (1981)). Additionally, in a rat lifetime oral administration test, it was reported that organ-specific effects on the urinary bladder were observed and bladder cancers appeared as with human (IARC 26 (1981)).</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Health Hazard</symbol>
  </toxic_to_reproduction>
  <systemic_toxicity_single_exposure hazard_type="health">
    <hazard_name>Reproductive toxicity</hazard_name>
    <hazard_id>7.0</hazard_id>
    <classification>Category 1A, Additional category: Effects on or via lactation</classification>
    <hazard_statement>May damage fertility or the unborn child
May cause harm to breast-fed children</hazard_statement>
    <rationale>It was reported that cyclophosphamide can damage the germinal cells in males and females and cause sterility in people of either sex (IARC 26 (1981)). It was also reported that no big toes or their respective metatarsals and phalanges, cleft palate, no coronary artery, eye and ear malformation and multiple abnormality were observed in infants from woman treated by the substance during pregnancy (IARC 26 (1981), Birth Defects (3rd, 2000)). Therefore, the substance was classified into Category 1A. In addition, the substance was classified as "Effects on or via lactation" based on a report that the excretion into breast milk was reported (JAPIC prescription drug book (2010)). Tests in animals have shown that cyclophosphamide is teratogenic in animal species such as mice, rats and rabbits (IARC 26 (1981)). There are reports of various malformations such as ophthalmic abnormality and skeletal defects (limb, finger) in rat and mouse tests (IARC vol. 26 (1981), Birth Defects (3rd, 2000)) and cleft palate and agnathia in a rabbit test (Birth Defects (3rd, 2000)).</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Health Hazard</symbol>
  </systemic_toxicity_single_exposure>
  <systemic_toxicity_repeat_exposure hazard_type="health">
    <hazard_name>Specific target organ toxicity - Single exposure</hazard_name>
    <hazard_id>8.0</hazard_id>
    <classification>Category 1 (bone marrow)</classification>
    <hazard_statement>Causes damage to organs (bone marrow)</hazard_statement>
    <rationale>Based on a report that the substance is an antitumor drug, has significant side effects, myelosuppression (decreased white blood cell count and platelet count) (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (bone marrow). As relevant information, in mouse, rat and dog tests, leucopenia and depression of thrombocytes were reported (IARC 26 (1981)).</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Health Hazard</symbol>
  </systemic_toxicity_repeat_exposure>
  <aspiration_hazard hazard_type="health">
    <hazard_name>Specific target organ toxicity - Repeated exposure</hazard_name>
    <hazard_id>9.0</hazard_id>
    <classification>Category 1 (bone marrow, heart, liver, immune system, systemic toxicity)</classification>
    <hazard_statement>Cause damage to organs through prolonged or repeated exposure (bone marrow, heart, liver, immune system, systemic toxicity)</hazard_statement>
    <rationale>Based on a report that the substance is an antineoplastic drug, has significant side effects, myelosuppression (cause pancytopenia, anemia, thrombocytopenia and hemorrhage) (JAPIC prescription drug book (2010)), and a report that myocardial disorder and cardiac failure occur at a frequency of 0.1 - 0.5% or less (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (bone marrow, heart). Since impaired liver function and jaundice are reported as significant side effects while the incidence is not specified (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (liver). Additionally, it was reported that administration of the substance can cause anaphylactoid reaction, hemorrhagic cystitis, oculomucocutaneous syndrome (Stevens-Johnson syndrome) however, frequencies are not specified. The substance can also cause ileus, gastrointestinal hemorrhage, interstitial pneumonia at a frequency of 0.1 - 0.5% or less (JAPIC prescription drug book (2010)). Since these symptoms are considered to involve the immune system, but the affected organ cannot be identified, the substance was classified into Category 1 (immune system, systemic toxicity). Based on all information, classification is Category 1 (bone marrow, heart, liver, immune system, systemic toxicity).</rationale>
    <signal_word>Danger</signal_word>
    <symbol>Health Hazard</symbol>
  </aspiration_hazard>
  <acute_aquatic_toxicity hazard_type="environmental">
    <hazard_name>Hazardous to the aquatic environment &#65288;Acute&#65289;</hazard_name>
    <hazard_id>11.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </acute_aquatic_toxicity>
  <chronic_aquatic_toxicity hazard_type="environmental">
    <hazard_name>Hazardous to the aquatic environment &#65288;Long-term&#65289;</hazard_name>
    <hazard_id>11.0</hazard_id>
    <classification>Classification not possible</classification>
    <hazard_statement> - </hazard_statement>
    <rationale>No data available.</rationale>
    <signal_word> - </signal_word>
    <symbol> - </symbol>
  </chronic_aquatic_toxicity>
</ghs_data>
